Moreover, pancreatic cancers commonly harbor mutations in additional tumour suppressor genes encoding for p14ARF and p16INK4A, p15INK4B and p27Kip1; key constituent proteins encompassing all three effector arms of the DNA origin activation checkpoint [28–33]. The gene discussed is CDKN2A; the disease is pancreatic neoplasm.